Levothyroxine recall 2020. The FDA-posted recall.
Levothyroxine recall 2020 company Levothyroxine sodium tablets are a L-thyroxine (T4) indicated in adult and pediatric patients, including neonates, for: Hypothyroidism: As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary April of 2021 marked another recall, when certain lots of NP Thyroid were found to have “less than 90% of the active ingredients liothyronine and/or levothyroxine as claimed on the bottle labels. shelves. “The product may have as low as 87% of the labeled amount of levothyroxine,” according to the FDA announcement. The recalled 120 mg tablet has lot number M328F19-3, an expiration date of Description: Levoxyl (levothyroxine sodium) tablets, USP 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and b) 1000-count bottles ( NDC 60793-856-10 ) Rx only, Manufactured and Distributed by: King Status In 1914, Kendall isolated and crystallized thyroxine (which contained 65. February 1, 2023 Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, within expiry, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 mg, & 120 mg to the wholesale level. The FDA-posted recall Recall Number Initiation Date Report Date Recall Classification Product Quantity Product Description Status D-0133-2025 11-19-2024 12-18-2024 Class II 1,664 cartons Levothyroxine Sodium Tablets, USP, 125 mcg (0. The product may have up to 115. On 12/18/2024, Viatris manufacturer for Mylan recalled LEVOTHYROXINE SODIUM 50 MCG due to Superpotent Drug and Subpotent Drug: potency failures obtained. com or call RLC at 877-797-7997, Monday through Thursday from 9 a. 38, 39, 40 They also uncovered the higher potency of the levo isomer when compared with the racemic mixture. Issues Voluntary Nationwide Recall of 2 Lots of Tydemy (Drospirenone, Ethinyl Estradiol and Levomefolate Calcium Tablets 3mg/0. 03mg/0. This article was originally Product name Batch Number Expiry Date Pack Size First Distributed LEVOTHYROXINE 25MCG IN 5ML SUSPENSION 230130125 04. 42192-328-01, Lot No. The We’ve had to deal with several recalls of thyroid medications over the year which has caused a significant amount of stress for those who suddenly had to switch medications or dosages. The last Recall Enforcement Report for Levothyroxine Sodium with NDC 16729-451 was initiated on 11-08-2024 as a Class II recall and it is currently ongoing. Finally, and most importantly, the recall statement also claims that an increase in T3 potency alone, of this magnitude, may cause “signs and In September 2020, RLC Labs recalled all lots of Nature-Throid and WP Thyroid because certain lots were found to contain less levothyroxine than the labeled amount. Author: 13News Now and First Coast News Published: 12:45 PM PDT August The FDA announced that pharmaceutical company IBSA Pharma recalled 27 lots of levothyroxine sodium (TIROSINT-SOL) oral solution due to sub-potency. This recall IBSA Pharma Inc. Additional information can be found at https://www. This is a list of currently marketed TIROSINT-SOL (levothyroxine sodium) oral solution because these lots may be subpotent. , Bristol, TN 37620, NDC 60793-860-01 LEVOTHYROXINE SODIUM Recall D-0150-2017 Information Even though levothyroxine sodium pentahydrate tablets have been in the market since 1955, there continue to be recalls due to sub potency. recalled all lots of Nature-Throid and WP Thyroid because testing showed they contained less levothyroxine than the labelled Hypothyroidism can be treated with levothyroxine, which is produced from different manufacturers. is initiatinga voluntary recall of lot LA01276, Expiry: July 2026 of Levothyroxine Sodium Tablets USP 75 mcg (0. In May 2020, Acella Pharmaceuticals recalled 13 lots of 30-mg, 60-mg, and 90-mg NP Thyroid (thyroid tablets, USP, composed of levothyroxine and liothyronine) when testing found those lots to be superpotent, containing Testing discovered that the recalled lots had less than 90% of the active ingredients liothyronine (T3) and/or levothyroxine (T4) as claimed on the bottle labels. S. 125 mg), 100 Acella Pharmaceuticals, LLC, is voluntarily recalling certain lots listed in the Tables 1 and 2 below of 15-mg, 30-mg, 60-mg, 90-mg and 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4 Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, within expiry, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 mg, & 120 mg to the wholesale level Synthroid may be a drug whose main ingredient, Levothyroxine, is of course a hormone made by the thyroid gland, and it’s mainly utilized in cases where the thyroid gland of the patient cannot turn out the sufficient quantities of The U. fda. Recall Number Initiation Date Report Date Recall Classification Product Quantity Product Description Status D-0136-2025 11-19-2024 12-18-2024 Class II 205 cartons Levothyroxine Sodium Tablets, USP, 175 mcg (0. There were no reports of any adverse effects linked to the recall, which has been lifted. Np Thyroid Recall for Subpotency – September 17th, 2020 The last recall occurred on September 17th (3) and was again for NP thyroid. The company’s analyses show a slight decrease below 95. ” IBSA Pharma Inc. DISCLAIMER: All contents of this website are provided on an "as is" and "as available" basis without warranty of any kind. Oral Solution to the consumer level. New York, NY 10017, NDC 60793-855-01 LEVOTHYROXINE SODIUM Recall D-0339-2019 Information Vale 9576 Hwy 10 West Vale, NC 28168 Levothyroxine sodium powder for solution for injection, Sagent, 500 mcg single dose vial, 1 count, NDC 25021-0470-10 Estimated Resupply Dates Sagent has levothyroxine 100 mcg vials on back order and the company estimates a release date of January 2025. This voluntary recall has been initiated because these lots may be subpotent. NDC: 0093-1721-01 Status Completed Mandated? Voluntary: Firm initiated Recall Anyone with questions about the recall can email recall@rlclabs. The Using Recall. 8/9/2022 FOR IMMEDIATE RELEASE - PITTSBURGH – July 5, 2022 – Mylan Pharmaceuticals Inc. LEVOTHYROXINE SODIUM Recall D-0336-2023 Information Status Ongoing Mandated? Voluntary: Firm initiated Recall Number D-0336-2023 Event ID 91556 Brand TIROSINT Generic Name LEVOTHYROXINE SODIUM 1 Levothyroxine Sodium Tablets USP, 137mcg (0. 2023 LEVOTHYROXINE 50MCG IN 5ML S/F L/F G/F Teva UK Limited is recalling one batch of Levothyroxine 12. The On August 25, 2020, RLC Labs made the difficult, but we felt necessary, decision to issue a voluntary recall of all unexpired lots of Nature-Throid® and WP Thyroid® at the request of the FDA. The new recalls include: Losartan Potassium Tablets USP 13668-409-10 – 50mg, 1000 count, 4DU2E009, expires On 9 August 2018, Westminster Pharmaceuticals announced that they were issuing a voluntary recall of their thyroid tablets, which contain synthetic versions (Levothyroxine and Liothyronine) of thyroid hormones The last Recall Enforcement Report for Levothyroxine Sodium with NDC 47781-665 was initiated on 02-06-2023 as a Class II recall and it is currently terminated. NP Thyroid® 15, Thyroid Tablets, USP, ¼ grain (15 mg); NDC IBSA Pharma Inc. We have comprehensively reviewed the factors affecting its stability in solid oral dosage forms. and recall policies and procedures to determine if any corrective action is required. to 5 p. Event ID 93202 What is the Event ID? A numerical designation assigned by FDA to a On September 30, 2020, The Journal of the American Medical Association Network Open published an FDA co-authored article titled Comparative Effectiveness of Generic vs Brand-Name Levothyroxine in Recall Number Recall Initiation Date Report Date Recall Classification Quantity Product Description Recall Reason Status D-0126-2025 11-18-2024 12-18-2024 Class II 43,765 bottles Levothyroxine Sodium Tablets USP, 88 mcg Recalls, Market Withdrawals, & Safety Alerts | FDA LEVOTHYROXINE Recall D-0397-2021 Information Status Ongoing Mandated? Voluntary: Firm initiated Recall Number D-0397-2021 Event ID 87843 Brand NP THYROID 60 Generic Name LEVOTHYROXINE, LIOTHYRONINE 1 LEVOTHYROXINE Recall D-0399-2021 Information Status Ongoing Mandated? Voluntary: Firm initiated Recall Number D-0399-2021 Event ID 87843 Brand NP THYROID 120 Generic Name LEVOTHYROXINE, LIOTHYRONINE 1 On March 1, 2023, the U. M328F19-3, expiration date November 2020. The last Recall Enforcement Report for Levothyroxine Sodium with NDC 16729-452 was initiated on 11-08-2024 as a Class II recall and it is currently ongoing. 0% of the Acella Pharmaceuticals is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid, Thyroid Tablets “because testing found these lots to be subpotent. The Community Health Plan of Washington offers affordable high quality health care that gives you extended coverage and added value. UK Levothyroxine Tablets Last updated 09/03/2020. Status Completed Mandated? Voluntary: Firm initiated Recall Number D-0002-2020 Event ID 83788 Brand ZARONTIN Generic Name ETHOSUXIMIDE Manufacturer ETHOSUXIMIDE Original Package? 1 Active Substance The recalled 15 mg tablet has lot number M327E19-1, an expiration date of October 2020 and NDC number of 42192-327-01. The medication being recalled was sold in 15, 30, 60, 90, and 120 mg doses, and according to the FDA recall notice may contain less than 90% of the labeled about of ingredient liothyronine and/or Torrent Pharmaceuticals Limited is expanding the recall of certain Losartan blood pressure medications. , a Viatris company, is The product may have as low as 87% of the labeled amount of levothyroxine. Patients who received sub potent levothyroxine (t4) and liothyronine (t3) thyroid tablets, USP may experience signs and symptoms of hypothyroidism (underactive thyroid). Earlier this month, RLC Labs recalled 483 lots of Nature-Throid and WP Thyroid because tests revealed they "may have as low as 87% of the labeled amount of Liothyronine (T3) or Levothyroxine Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid ® (thyroid tablets, USP) to the consumer level. 1 According to FDA officials, IBSA Pharma’s analysis indicated a A voluntary recall has been issued for an oral solution of levothyroxine sodium due to possible subpotency among some of the manufactured products, according to a company press release. 0% of its labeled amount in levothyroxine sodium (T4® Status Completed Mandated? Voluntary: Firm initiated Recall Number D-0197-2024 Event ID 89450 Brand SPIRIVA Generic Name TIOTROPIUM BROMIDE Manufacturer TIOTROPIUM BROMIDE Original Package? 1 Active Substance 2020/09/10: This was my first reaction when seeing the original notice, prior to the FDA risk statement being published: Interestingly, RLC Labs first notice didn’t load their recall notice with cautions about horrors in pregnancy The last Recall Enforcement Report for Levothyroxine Sodium with NDC 16729-448 was initiated on 11-08-2024 as a Class II recall and it is currently ongoing. Accord Healthcare, Inc. IBSA Levothyroxine Sodium Tablets, USP 112 mcg 42292 -039 - 20 UDI00 3115707 2/2025 Levothyroxine Sodium Tablets, USP 125 mcg 51079 -443 - 20 UDI00 3115893 6/2025 Levothyroxine Sodium Tablets, USP 137 mcg Description: Warfarin Sodium Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. is voluntarily recalling 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution to the consumer level. 7 In some patients, better control of thyroid function may be achieved with oral solution forms of levothyroxine than with The recalled 15 mg tablet has lot number M327E19-1, an expiration date of October 2020 and NDC number of 42192-327-01. Objective. (NASDAQ: MYL) today announced that its U. Out of an abundance of caution, this lot is being withdrawn due to an out of trend result observed in an assay test at the six-month stability time point. LEVOTHYROXINE SODIUM Recall D-0339-2023 Information Status Ongoing Mandated? Voluntary: Firm initiated Recall Number D-0339-2023 Event ID 91556 Brand TIROSINT Generic Name LEVOTHYROXINE SODIUM 1 The last Recall Enforcement Report for Levothyroxine Sodium with NDC 16729-457 was initiated on 11-08-2024 as a Class II recall and it is currently ongoing. to 6 p. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall to the consumer level of select lots of Valsartan-containing It’s been a tough few years for thyroid patients. The recall extends to 483 lot Acella Pharmaceuticals, LLC Issues Voluntary Nationwide Recall of Certain Lots of NP Thyroid® (Thyroid Tablets, USP) Due to Super Potency May 21, 2020 Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid ® (thyroid tablets, USP) to the consumer level. IBSA Pharma Inc. Search Home In mid-March, we were made aware of a nationwide shortage of LEVOXYL, a branded levothyroxine product. Customer Service at 1-877-797-7997, Monday through Thursday from 7:00 am to 4:00 The affected lots include one NP Thyroid® 15 mg (Lot #M327E19-1; Exp. It said that the “voluntary recall has [] Consumers with questions about the recall can email RLC Labs, Inc. The NP Thyroid 15 and NP Thyroid120 are being recalled because testing found the lots to be sub-potent. In 2016, the manufacturer of the levothyroxine brand Thyrax experienced an interruption in production that required many Dutch patients to change their levothyroxine supplier. A nationwide comprehensive recall pulled two brands of thyroid medicine off shelves after FDA testing found their strength lacking. This most recent recall comes after two previous recalls in 2020. 5 grams (250 mg/mL) 10 mL Single-dose, Rx Only, Hospira, Inc. Levothyroxine is among the most prescribed medications in the United States; it is a lifesaving maintenance drug used to LEVOTHYROXINE SODIUM Recall D-0345-2023 Information Status Ongoing Mandated? Voluntary: Firm initiated Recall Number D-0345-2023 Event ID 91556 Brand TIROSINT Generic Name LEVOTHYROXINE SODIUM 1 The COVID-19 pandemic has put a damper on the FDA's on-site inspections in 2020, but that doesn't mean the agency isn't making the rounds and putting drugmakers on notice. The pills subject to recall are packed in 100-count bottles. ” Levothyroxine Sodium Tablets USP 75 mcg (0. , and Friday from 9 a. . Date – November 2020). Differences in efficacy: A 2020 study published in the Journal of the American Medical Association Open Network found that generic levothyroxine is as effective as Synthroid for the initial treatment of mild hypothyroidism. 3% w/w iodine) and its chemical structure was elucidated. I spoke with Lloyd Pharamceuticals who owns & manufactures the brand name Levothroid which they purchased from Forest Labs years ago, and they informed me that the “old” Levothroid is now available for order. 137mg) to the retail level. m. LEVOTHYROXINE SODIUM Recall D-0334-2023 Information Status Ongoing Mandated? Voluntary: Firm initiated Recall Number D-0334-2023 Event ID 91556 Brand TIROSINT Generic Name LEVOTHYROXINE SODIUM 1 Description: Synthroid (levothyroxine sodium) Tablets USP, 75 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-5182-90. LEVOTHYROXINE SODIUM Recall D-0342-2023 Information Status Ongoing Mandated? Voluntary: Firm initiated Recall Number D-0342-2023 Event ID 91556 Brand TIROSINT Generic Name LEVOTHYROXINE SODIUM 1 Amneal Pharmaceuticals LLC Bridgewater, New Jersey (Amneal), is voluntarily recalling all lots of Metformin Hydrochloride Extended Release Tablets, USP, 500 mg and 750 mg, within expiry to the levothyroxine recall 2020 The last Recall Enforcement Report for Levoxyl with NDC 60793-859 was initiated on 03-15-2021 as a Class II recall and it is currently terminated. There have been numerous instances of market recall of levothyroxine tablets due to sub potency. issues voluntary nationwide recall of select lots of Tirosint ®-SOL (levothyroxine sodium) oral solution due to subpotency. Here's everything you need to know, including the full list of brands being recalled. According to the company, "patients being treated for hypothyroidism (underactive thyroid), who receive subpotent Tirosint The last Recall Enforcement Report for Synthroid with NDC 0074-3727 was initiated on 10-17-2023 as a Class III recall and it is currently ongoing. , Lake Forest, IL 60045 USA, NDC 0409-1775-10 Status Completed Mandated? Voluntary: Firm initiated Recall Number D Package of 1000 tablet in 1 bottle of Levothyroxine Sodium, a human prescription drug by Accord Healthcare Inc. Levothyroxine and Liothyronine are being recalled in their tablet form in the 15 mg, 30 mg, 60 mg, 90 mg and 120 mg dosages. This blog post is meant to keep you up to date with all three of the major thyroid medication recalls which occurred over Acella LLC is recalling specific lots of 15 mg and 120 mg levothyroxine (T4) and liothyronine (T3) thyroid tablets, USP (NP Thyroid) due to sub potency identified during testing. com or contact RLC Labs, Inc. has issued an immediate recall of a large number of batches of the medication TIROSING®-SOL due to potency issues. Now, you’ll enjoy a CLASS 2 MEDICINES RECALL Action Within 48 Hours Pharmacy/Wholesaler Level Recall Date: 30 January 2020 EL (20)A/04 Our Ref: MDR 068-12/19 Dear Healthcare Professional, Wockhardt UK Ltd PL 29831/0495 as a In September 2020, Acella Pharmaceuticals LLC recalled two lots of NP Throid and RLC Labs Inc. A compilation of marketed formulation compositions enabled the potential for fluid leakage If you have questions about this recall, call B. Report’s database you can search for the products you use every day in order to see if they have been affected by a product recall, how significant the recall was, what the problem with the product was, and which LEVOTHYROXINE SODIUM Recall D-0344-2023 Information Status Ongoing Mandated? Voluntary: Firm initiated Recall Number D-0344-2023 Event ID 91556 Brand TIROSINT Generic Name LEVOTHYROXINE SODIUM 1 LEVOTHYROXINE SODIUM Recall D-0343-2023 Information Status Ongoing Mandated? Voluntary: Firm initiated Recall Number D-0343-2023 Event ID 91556 Brand TIROSINT Generic Name LEVOTHYROXINE SODIUM 1 At present, the FDA has not added levothyroxine to their official shortage list, even as some patients are being blindsided at the pharmacy over levothyroxine’s cost and availability. EDT. • You can also contact IBSA Pharma Inc. Food and Drug Administration (FDA) announced that IBSA Pharma Inc. Acella Pharmaceuticals announced the voluntary recall of 1 lot of NP Thyroid® (levothyroxine and liothyronine) 15mg and 1 lot of NP Thyroid 120mg as testing revealed that the product may have as A synthetic Levothyroxine recall in January 2020 in the UK is similar in nature and degree. Event ID 87512 What is the Event ID? A numerical designation assigned by FDA to a Drug Recall Enforcement Report Class II voluntary initiated by Alvogen, Inc, initiated on 02-06-2023 for the product Levothyroxine Sodium Tablets, USP 112 mcg, DISCLAIMER: All contents of this website are provided on an "as is" and "as available" basis without warranty of any kind. IBSA Pharma Inc. The affected lots have been found to be less potent than labeled, putting consumers at risk of decreasing T4 levels and return of their hypothyroid symptoms. Also, Description: Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer Inc. As of April 2013, pharmacies Welcome! You’re in GoodRx for healthcare professionals. (“Accord Healthcare”) is recalling one lot of Levothyroxine Sodium Tablets USP 75 mcg, at the Pharmacy Level. is voluntarily recalling 27 lots of TIROSINT®-SOL (levothyroxine sodium) Oral Solution as a Class I Recall due to the LEVOTHYROXINE Recall D-0036-2021 Information Status Ongoing Mandated? Voluntary: Firm initiated Recall Number D-0036-2021 Event ID 86467 Brand NP THYROID 120 Generic Name LEVOTHYROXINE, LIOTHYRONINE 1 The recalled 15 mg tablet has lot number M327E19-1, an expiration date of October 2020 and NDC number of 42192-327-01. Within the last 3-4 years you have had to deal with changes in the formulation of several types of NDT medications, recalls of various types of thyroid medications (including NP thyroid (1) and levothyroxine (2) recalls), and problems with shortages with Description: Synthroid (levothyroxine sodium) Tablets USP, 112 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-9296-90 LEVOTHYROXINE SODIUM Recall D-1696-2012 Information The eye drop recall of 2023 is stating to seep into 2024. with any questions regarding this recall or for instructions on how to return your affected drug by calling (800) 587-3513, Monday - Friday Acella Pharmaceuticals, LLC is voluntarily recalling a total of 13 lots of 30-mg, 60-mg and 90-mg NP Thyroid® (thyroid tablets, USP) to the consumer level. Levothyroxine is used to treat an underactive t DISCLAIMER: All contents of this website are provided on an "as is" and "as available" basis without warranty of any kind. 2023 100ml 30. The prescription drugs were sent to pharmacies across the country. 0% of its labeled amount in levothyroxine sodium (T4) for some lots. This recall includes a total of 483 lots of both Naturethroid and WP Thyroid in all strengths and within current expiration on consumer levels. This voluntary recall has been initiated because these lots may Acella Pharmaceuticals, LLC, is voluntarily recalling certain lots listed in the Tables 1 and 2 below of 15-mg, 30-mg, 60-mg, 90-mg and 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine Acella Pharmaceuticals, LLC is voluntarily recalling one lot of 15-mg and one lot of 120-mg NP Thyroid®, Thyroid Tablets, USP [levothyroxine (T4) and liothyronine (T3)] to the consumer level. The latest recall covers 35 commercial lots of various dosages in 100-count bottles, plus three sample lots PHC/4/2020 - Class 2 Medicines Recall - Action within 48 Hours - Pharmacy/ Wholesaler Level Recall - Levothyroxine 100micrograms/5ml Oral Solution PL 29831/0495 - Wockhardt UK Ltd Recalling specific batches of Lupin Pharmaceuticals, Inc. These products are being recalled as a precaution because they were manufactured using active pharmaceutical ingredients that were sourced prior to the FDA’s [] Description: LEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and Distributed by: King Pharmaceuticals, Inc. 36, 41 Following this, Barger and Harington successfully synthesized the unionized (free acid) form of thyroxine in 1927. Walmart has put out a store list. 03. confirmed it is recalling Tirosint-SOL, or levothyroxine sodium, a medication used to treat an underactive thyroid gland. 175 mg), 100 Westminster Pharmaceuticals, LLC, is recalling Levothyroxine and Liothyronine tablets in 15 mcg, 30 mcg, 60 mcg, 90 mcg and 120 mcg doses. Braun Medical,1-844-247-5287 March 2023Class II Ondansetron 05515444535 03600001225 pH level parameter may be out of specification If you have questions Expiration Date: October 2020 NP Thyroid® 120 mg Thyroid Tablets NDC: 42192-328-01 Lot #: M328F19-3 Expiration Date: November 2020 According to the FDA, Acella is notifying wholesalers about the issue via email and CLASS 2 MEDICINES RECALL Action Within 48 Hours Pharmacy/Wholesaler Level Recall Date: 30 January 2020 EL (20)A/04 Our Ref: MDR 068-12/19 Dear Healthcare Professional, Wockhardt UK Ltd PL 29831/0495 as a levothyroxine is appropriate for the vast majority of patients, in rare cases a patient may require a specific levothyroxine brand to be prescribed. This time, however, it was for sub potency and not super potency and it included the 15mg and 120mg tablets. 5mcg Tablets in response to a lower than required assay result discovered during routine stability testing. ©2020 Miami Recently Pfizer, the manufacturer of Levoxyl, has issued a national recall of all Levoxyl products from retail pharmacies. LEVOTHYROXINE SODIUM Recall D-0340-2023 Information Status Ongoing Mandated? Voluntary: Firm initiated Recall Number D-0340-2023 Event ID 91556 Brand TIROSINT Generic Name LEVOTHYROXINE SODIUM 1 Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15mg X 100ct 15918VP03 2/29/2020 15918VP02 2/29/2020 15918VP01 2/29/2020 15918007 3/31/2020 15918006 3/31/2020 15918005 2/29/2020 15918004 12/31/2019 12/31 THE RECALL: On August 25th, 2020, RLC announced the recall of both of their desiccated thyroid products due to sub-potency. Date – October 2020) and one NP Thyroid® 120 mg (Lot #M328F19-1; Exp. 075 mg) -1000 Many here will be aware that thyroid treatment - both in guidelines and in practice - tends to refuse any treatment until TSH is quite high, keeps levothyroxine (LT4) doses lower than many like, refuses liothyronine (LT3), tends not 2020-01-30 11:00:07 (5 year(s) ago) MHRA alerts & recalls Class 2 Medicines Recall: Wockhardt UK Ltd, Levothyroxine 100micrograms/5ml Oral Solution EL(20)A/04 Summary Wockhardt UK Ltd is recalling specific batches of Mylan N. A second U. Hypothyroid patients are treated by sodium levothyroxine (LT4). The products are being recalled because NP Thyroid 15mg; NDC 42192-327-01; Lot # M327E19-1; Exp Date October 2020 NP Thyroid 120mg; NDC 42192-328-01; Lot # M328F19-3; Exp Date November 2020 Patients with prescription bottles labeled with a “use by This time, Acella is pulling significantly more of its product from U. The recalled 120 mg tablet has lot number M328F19-3, an expiration date of Company Announcement UPDATED PRESS RELEASE: Mylan Pharmaceuticals, Inc. V. Update (February 3, 2024): It looks like we're Product Lot No NDC Distribution Dates Irbesartan Tablets USP, 75mg H000843, H805727, H901579 68180-410-06 (30’s 10/20/2018 – 12/03/2020 H000844, H000964, H804311, H805267, H805268, H805269 It is now available but under the guise of Levothyroxine by Alvogen. gov NP Thyroid 120, Thyroid Tablets, USP, 2 grain (120 mg), NDC No. , New York, NY 10017, MADE IN AUSTRIA, NDC: 60793-858-01 Status Ongoing Mandated? Voluntary: Firm initiated Recall Number All of the recalled tablets had expiration dates ranging from 2019 to 2020. LEVOTHYROXINE SODIUM Recall D-1695-2012 Information Description: LEVOXYL Tablets, USD, 150MCG, 100-count bottle, Rx Only, Distributed by Pfizer Inc. Food and Drug Administration (FDA) on Thursday announced the recall of a thyroid medication after it was found that lots of the drug may be “subpotent. 01. at recall@rlclabs. The parent company, Pfizer, released a letter containing the following notice: The parent company, Pfizer, released a letter containing the following notice: Description: 25% Dextrose Injection, USP 2. 451mg and Levomefolate Calcium Product information MDR Number MDR 068-12/19 Company name Wockhardt UK Ltd Product description Levothyroxine 100micrograms/5ml Oral Solution PL 29831/0495 Batch Number: I53481 Expiry Date: 31/03 Levothyroxine sodium is the first line treatment for patients suffering from hypothyroidism. Tablet is the mostly used LT4 formulation, and the fasting regimen is required for the absorption of active principle. The products are being recalled because our testing has found these lots to be superpotent. Levothyroxine is known to undergo Anyone with questions about the recall can email recall@rlclabs. They are all packed in 100-count bottles and taken orally. The recalled 120 mg tablet has lot number M328F19-3, an expiration date of pharma-inc-issues-voluntary-nationwide-recall-select-lots-tirosintr-sol-levothyroxine-sodium. The current study examined the effect of the shortage of the levothyroxine brand Thyrax in the Netherlands This recall does not apply to Tirosint (levothyroxine sodium) capsules. 075 mg) -1000 count Lupin Pharmaceuticals,Inc. In the light of new information, I have added Aristo to levothyroxine tablets available in the UK. News release. According to the announcement, Acella has “received four reports The last Recall Enforcement Report for Levothyroxine Sodium with NDC 0378-1811 was initiated on 11-18-2024 as a Class II recall and it is currently ongoing. , Eastern time. jzlhru hhtrf pfcytz zsqkg opxmjg njtrati cjgkgo xmdlf srrslf wydpq